DHSC 29 October 2020
- Report on the service providing sterile, controlled environments for the preparation of injectable medicines into 'ready to administer' formats for patients. This report recommends investment in hubs to produce aseptic injectable medicines in England in order to create high volumes of aseptic pharmacy products which will: save time for nursing staff, enable care closer to home, produce significant savings.
